Annotation Detail for ARSD
Basic Information
Top
| Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
|---|
| D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of ARSD mRNA | decreases expression | 20106945
|
| D019833 |
Genistein |
Genistein results in decreased expression of ARSD mRNA | decreases expression | 19371625
|
| Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
|---|
| MESH:D000230 |
Adenocarcinoma |
|
Genistein |
2.56 | 11473722 |
| MESH:D001943 |
Breast Neoplasms |
|
Genistein |
2.48 | 16541309 17200150 16873071 |
| MESH:D006528 |
Carcinoma, Hepatocellular |
|
Genistein |
2.18 | 16924424 |
| MESH:D002318 |
Cardiovascular Diseases |
|
Genistein |
3.63 | 16332659 |
| MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
2.85 | 12371664 |
| MESH:D002779 |
Cholestasis |
|
Cyclosporine |
3.28 | 19486331 |
| MESH:D003110 |
Colonic Neoplasms |
|
Genistein |
2.34 | 17182828 |
| MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Genistein |
2.57 | 16647724 |
| MESH:D004714 |
Endometrial Hyperplasia |
|
Genistein |
5.48 | 16402032 |
| MESH:D016889 |
Endometrial Neoplasms |
|
Genistein |
3.66 | 11473722 |
| MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
3.40 | 19224547 |
| MESH:D005355 |
Fibrosis |
|
Cyclosporine |
3.90 | 12168785 12639820 |
| MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
5.11 | 8708960 |
| MESH:D005909 |
Glioblastoma |
|
Genistein |
3.55 | 16598420 |
| MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
5.31 | 15720958 |
| MESH:D006973 |
Hypertension |
|
Cyclosporine |
2.24 | 10903974 |
| MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
5.51 | 15604871 |
| MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
2.58 | 18776723 10903974 8314463 |
| MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
3.17 | 12371664 |
| MESH:D007938 |
Leukemia |
|
Genistein |
3.22 | 18980019 17468513 |
| MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Genistein |
2.07 | 17823541 |
| MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Genistein |
3.23 | 12929590 14578162 |
| MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
5.86 | 16801185 |
| MESH:D009203 |
Myocardial Infarction |
|
Genistein |
3.02 | 17141266 |
| MESH:D015428 |
Myocardial Reperfusion Injury |
|
Genistein |
4.04 | 17141266 |
| MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
5.51 | 17954296 |
| MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.75 | 18481113 19348381 |
| MESH:D009421 |
Nervous System Malformations |
|
Genistein |
4.71 | 16427766 |
| MESH:D010024 |
Osteoporosis |
|
Genistein |
3.52 | 19401787 |
| MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Genistein |
4.69 | 16169203 |
| MESH:D010051 |
Ovarian Neoplasms |
|
Genistein |
2.71 | 19005980 |
| MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
3.69 | 12371664 |
| MESH:D011471 |
Prostatic Neoplasms |
|
Genistein |
3.39 | 16925846 15256057 15378649 |
| MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.35 | 16882103 |
| MESH:D014605 |
Uveitis |
|
Cyclosporine |
5.05 | 1336536 |
| MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
5.51 | 17120751 |
Related Pathway Information